Insulin delivery through nasal route using thiolated microspheres

被引:12
作者
Nema, Tarang [1 ]
Jain, Ashish [1 ]
Jain, Aviral [1 ]
Shilpi, Satish [1 ]
Gulbake, Arvind [1 ]
Hurkat, Pooja [1 ]
Jain, Sanjay K. [1 ]
机构
[1] Dr HS Gour Vishwavidyalaya, Dept Pharmaceut Sci, Pharmaceut Res Projects Lab, Sagar, MP, India
关键词
Carbopol-cysteine; insulin; mucoadhesion; nasal delivery; thiomer; DRUG-DELIVERY; ANIMAL-MODELS; IN-VITRO; CHITOSAN; POLYMERS; SYSTEMS; THIOMERS;
D O I
10.3109/10717544.2012.746401
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of the present study was to investigate the potential of developed thiolated microspheres for insulin delivery through nasal route. In the present study, cysteine was immobilized on carbopol using EDAC. A total of 269.93 mu mol free thiol groups per gram polymer were determined. The prepared nonthiolated and thiolated microspheres were studied for particle shape, size, drug content, swellability, mucoadhesion and in vitro insulin release. The thiolated microspheres exhibited higher mucoadhesion due to formation of covalent bonds via disulfide bridges with the mucus gel layer. Drug permeation through goat nasal mucosa of nonthiolated and thiolated microspheres were found as 52.62 +/- 2.4% and 78.85 +/- 3.1% in 6 h, respectively. Thiolated microspheres bearing insulin showed better reduction in blood glucose level (BGL) in comparison to nonthiolated microspheres as 31.23 +/- 2.12% and 75.25 +/- 0.93% blood glucose of initial BGL were observed at 6 h after nasal delivery of thiolated and nonthiolated microspheres in streptozotocin-induced diabetic rabbits.
引用
收藏
页码:210 / 215
页数:6
相关论文
共 19 条
  • [1] Polymers with thiol groups:: A new generation of mucoadhesive polymers?
    Bernkop-Schnürch, A
    Schwarz, V
    Steininger, S
    [J]. PHARMACEUTICAL RESEARCH, 1999, 16 (06) : 876 - 881
  • [2] Thiomers:: potential excipients for non-invasive peptide delivery systems
    Bernkop-Schnürch, A
    Krauland, AH
    Leitner, VM
    Palmberger, T
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2004, 58 (02) : 253 - 263
  • [3] Nasal delivery of insulin using novel chitosan based formulations: A comparative study in two animal models between simple chitosan formulations and chitosan nanoparticles
    Dyer, AM
    Hinchcliffe, M
    Watts, P
    Castile, J
    Jabbal-Gill, I
    Nankervis, R
    Smith, A
    Illum, L
    [J]. PHARMACEUTICAL RESEARCH, 2002, 19 (07) : 998 - 1008
  • [4] Rheological evaluation of poloxamer as an in situ gel for ophthalmic use
    Edsman, K
    Carlfors, J
    Petersson, R
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 6 (02) : 105 - 112
  • [5] Intranasal insulin delivery and therapy
    Hinchcliffe, M
    Illum, L
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 1999, 35 (2-3) : 199 - 234
  • [6] Nasal delivery. The use of animal models to predict performance in man
    Illum, L
    [J]. JOURNAL OF DRUG TARGETING, 1996, 3 (06) : 427 - 442
  • [7] CHITOSAN AS A NOVEL NASAL DELIVERY SYSTEM FOR PEPTIDE DRUGS
    ILLUM, L
    FARRAJ, NF
    DAVIS, SS
    [J]. PHARMACEUTICAL RESEARCH, 1994, 11 (08) : 1186 - 1189
  • [8] Thiolated chitosan microparticles:: A vehicle for nasal peptide drug delivery
    Krauland, AH
    Guggi, D
    Bernkop-Schnürch, A
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 307 (02) : 270 - 277
  • [9] Thiomers:: development and in vitro evaluation of a peroral microparticulate peptide delivery system
    Krauland, AH
    Bernkop-Schnürch, A
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2004, 57 (02) : 181 - 187
  • [10] PRESENT AND FUTURE APPLICATIONS OF BIOMATERIALS IN CONTROLLED DRUG DELIVERY SYSTEMS
    LANGER, RS
    PEPPAS, NA
    [J]. BIOMATERIALS, 1981, 2 (04) : 201 - 214